Skip to content
Homepage
Author:
NEURIZON THERAPEUTICS LIMITED
Posted Date:
July 16, 2026
HEALEY ALS Platform Trial Regimen I enrolment completed – Topline results for NUZ-001 accelerated to Q2 CY2027
NEURIZON THERAPEUTICS LIMITED
July 16, 2026
HEALEY ALS Platform Trial Regimen I expands to 240 participants
NEURIZON THERAPEUTICS LIMITED
May 29, 2026
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
NEURIZON THERAPEUTICS LIMITED
February 26, 2026
